Skip to main content

Affinity Asset Advisors, LLC

Position in CRSP — CRISPR Therapeutics AG

CIK 1773195 NEW YORK, NY

Position in CRSP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,454,000
-$1,681,500 QoQ
Shares Held
100,000
-33.3% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#69
of 521 holders
Holding Since
Dec 2020
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRSP Over Time

Shares Held

Position Value (USD)

Derivatives in CRSP

reported options exposure · as of Jun 30, 2025
CallValue
$9,728,000
CallShares
200,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Affinity Asset Advisors, LLC holds $1,842,784,374 across 87 Biotechnology names. CRSP ranks #58 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRSP

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,454,000 100,000
2026-03-31 $7,135,500 150,000
2025-06-30 $9,728,000 200,000
2024-03-31 $4,430,400 65,000
2022-06-30 $4,253,900 70,000
2022-03-31 $3,452,350 55,000
2020-12-31 $535,885 3,500